SCHEMBL30721027

SCHEMBL30721027

CCn1c(Cl)nc2c(Br)cc(C)cc2c1=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DDR1 Q08345 3/20 0.42
▸ KDM4E B2RXH2 3/20 0.40
▸ ALDH1A1 P00352 2/20 0.40
▸ HPGD P15428 2/20 0.40
▸ HTT P42858 2/20 0.40
▸ HSD17B10 Q99714 2/20 0.40
▸ RXFP1 Q9HBX9 2/20 0.40
▸ EGFR P00533 1/20 0.40
▸ GLA P06280 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ TSHR P16473 1/20 0.36
▸ BTK Q06187 1/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25360747 1.00 DDR1 (0.42) DDR1KDM4EALDH1A1HPGDHTT
SCHEMBL30784492 0.87 CYP1A2 (0.41) DDR1KDM4EALDH1A1HPGDHTT
SCHEMBL30784349 0.87 DDR1 (0.38) DDR1KDM4EALDH1A1HPGDHTT
SCHEMBL30784134 0.84 DDR1 (0.38) DDR1ALDH1A1HTTEGFRTSHR
SCHEMBL30784327 0.83 ALDH1A1 (0.47) DDR1ALDH1A1HPGDHSD17B10RXFP1
SCHEMBL30784012 0.81 PDE1A (0.38) DDR1HTTRXFP1EGFRCYP3A4
SCHEMBL30336004 0.81 EGFR (0.43) DDR1KDM4EALDH1A1HPGDHTT
SCHEMBL25360881 0.81 EGFR (0.43) DDR1KDM4EALDH1A1HPGDHTT
SCHEMBL15228801 0.78 ALDH1A1 (0.45) KDM4EALDH1A1HPGDHTTHSD17B10
SCHEMBL30784404 0.77 EGFR (0.40) DDR1ALDH1A1HPGDHTTRXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024000401-A1 2-((1-(6-METHYL-4-OXO-3,4-DIHYDROQUINAZOLIN-8-YL)ETHYL)AMINO)BENZOIC ACID DERIVATIVES AND SIMILAR COMPOUNDS AS PI3K INHIBITORS FOR THE TREATMENT OF E.G. CANCER QILU REGOR THERAPEUTICS INC. (CN) 2024-01-04 — — WO disclosed
Send feedback